MicroRNAs in idiopathic pulmonary fibrosis: involvement in pathogenesis and potential use in diagnosis and therapeutics - ScienceDirect
Genetic Risk Factors for Idiopathic Pulmonary Fibrosis: Insights into | JIR
IJMS | Free Full-Text | Idiopathic Pulmonary Fibrosis: Pathogenesis and the Emerging Role of Long Non-Coding RNAs | HTML
Idiopathic pulmonary fibrosis: Are any of the morphological-molecular markers useful in clinical management? | Semantic Scholar
Reprogramming of profibrotic macrophages for treatment of bleomycin‐induced pulmonary fibrosis | EMBO Molecular Medicine
Frontiers | Dissecting the Role of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis: Cause or Solution
Unifying mechanism for different fibrotic diseases | PNAS
Recent Advances in Molecular Diagnosis of Pulmonary Fibrosis for Precision Medicine | ACS Pharmacology & Translational Science
Genetic Risk Factors for Idiopathic Pulmonary Fibrosis: Insights into | JIR
Frontiers | The Processes and Mechanisms of Cardiac and Pulmonary Fibrosis
Targeting Runt-Related Transcription Factor 1 Prevents Pulmonary Fibrosis and Reduces Expression of Severe Acute Respiratory Syndrome Coronavirus 2 Host Mediators - The American Journal of Pathology
Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic? - The Lancet Respiratory Medicine
The histone methyltransferase DOT1L is a new epigenetic regulator of pulmonary fibrosis | Cell Death & Disease
MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program | Science Advances
The pathogenesis of pulmonary fibrosis: a moving target | European Respiratory Society
Administration of aloperine attenuated lung fibrosis after BLM... | Download Scientific Diagram
Molecular biomarkers in idiopathic pulmonary fibrosis | American Journal of Physiology-Lung Cellular and Molecular Physiology
Club cell-specific role of programmed cell death 5 in pulmonary fibrosis | Nature Communications
Biomedicines | Free Full-Text | Asthma and Post-Asthmatic Fibrosis: A Search for New Promising Molecular Markers of Transition from Acute Inflammation to Pulmonary Fibrosis | HTML
Matrix regulation of idiopathic pulmonary fibrosis: the role of enzymes | Fibrogenesis & Tissue Repair | Full Text
Expression levels of fibrosis and inflammatory markers in cultured... | Download Scientific Diagram
The potential indicators for pulmonary fibrosis in survivors of severe COVID-19 - Journal of Infection
Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-β mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems - ScienceDirect
Fibroblasts and their responses to chronic injury in pulmonary fibrosis - ScienceDirect
